Eiger Biopharma (EIGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIGR | BMY | AMGN | GILD | REGN |
| Company | Eiger Biopharma | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.9000 | 44.68 | 265.72 | 65.50 | 881.72 |
| High | 1.9000 | 45.37 | 271.68 | 66.35 | 887.48 |
| Low | 1.6600 | 44.34 | 265.72 | 64.63 | 875.23 |
| Last | 1.7250 | 45.11 | 271.02 | 65.58 | 883.52 |
| Change | -0.1750 | +0.41 | +1.64 | +0.31 | -7.16 |
| % Change | -9.21% | +0.92% | +0.61% | +0.47% | -0.80% |
| Volume | 137,800 | 11,959,108 | 1,068,601 | 9,117,759 | 320,908 |
| 20-Day Average Volume | 338,745 | 12,707,475 | 2,083,976 | 6,879,647 | 446,670 |
| Previous Close | 1.9000 | 44.70 | 269.38 | 65.27 | 890.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.9527 | 49.49 | 270.04 | 68.31 | 918.57 |
| 20-Day Raw Stochastic | 10.25% | 9.35% | 44.94% | 13.10% | 8.90% |
| 20-Day Relative Strength | 31.39% | 31.37% | 46.69% | 31.13% | 33.20% |
| Weighted Alpha | -91.57 | -33.56 | +10.09 | -22.94 | +9.90 |
| Today's Opinion | 100% Sell | 88% Sell | 56% Sell | 100% Sell | 8% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 56% Sell | 8% Buy | 40% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.55% since 04/03/24 | -7.49% since 04/19/24 | +0.81% since 04/19/24 | -1.51% since 04/19/24 | -1.47% since 04/19/24 |
| Low | 1.6600 on 04/10/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 2.8798 on 04/04/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 915.70 on 04/24/24 |
| 1-Month | |||||
| %Chg | -75.05% since 03/08/24 | -13.86% since 03/26/24 | -3.78% since 03/26/24 | -9.19% since 03/26/24 | -8.29% since 03/26/24 |
| Low | 1.1000 on 04/01/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 7.2641 on 03/11/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -76.78% since 01/10/24 | -8.92% since 01/26/24 | -13.04% since 01/26/24 | -17.31% since 01/26/24 | -6.00% since 01/26/24 |
| Low | 1.1000 on 04/01/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 8.2672 on 03/04/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -78.78% since 10/10/23 | -14.55% since 10/26/23 | +0.52% since 10/26/23 | -16.24% since 10/26/23 | +11.57% since 10/26/23 |
| Low | 1.1000 on 04/01/24 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 769.19 on 10/27/23 |
| High | 14.3370 on 11/20/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,554 | 90,596,128 | 144,488,960 | 81,266,176 | 97,762,816 |
| Shares Outstanding, K | 1,481 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 13,480,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -96,780,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 3,210,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -18,030,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.83 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -12.31 on 11/09/23 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 9.98 | 24.12 |